Back to search
FDAFDA · Food and drugs·Recall number D-0227-2026

Sertraline Hydrochloride Tablets USP, 100 mg, 90 Tablets bottles, Rx Only, Manufactured by: Lupin Pharmaceuticals, Inc., Naples, FL 34108, NDC 68180-353-09.

Published December 17, 2025 · Recall initiated: November 5, 2025

Summary

FDA records drug Class II recall D-0227-2026, published December 17, 2025 and initiated November 5, 2025. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Ongoing; Reported quantity: 52,128 bottles; Lot: Lot # QB00865, exp. date Feb 2028. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective container - seal not adhering to bottles

What to do

Voluntary: Firm initiated · Letter

Get an email if SERTRALINE HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
SERTRALINE HYDROCHLORIDE
Manufacturer
Lupin Pharmaceuticals Inc.
Distributor
Nationwide.
Lot
Lot # QB00865, exp. date Feb 2028
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Sertraline Hydrochloride Tablets USP, 100 mg, 90 Tablets bottles, Rx Only, Manufactured by: Lupin Pharmaceuticals, Inc., Naples, FL 34108, NDC 68180-353-09. recalled?

Yes. FDA published recall D-0227-2026 on December 17, 2025. Reported hazard: Defective container - seal not adhering to bottles

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: SERTRALINE HYDROCHLORIDE.